Supporting Meal Management in Type 1 Diabetes (SUMMIT1)
Type 1 Diabetes
About this trial
This is an interventional prevention trial for Type 1 Diabetes focused on measuring Carbohydrates, Continuous glucose measurement, Closed-loop systems, Type 1 Diabetes, Hyperglycaemia, Hypoglycaemia
Eligibility Criteria
Inclusion Criteria: Written informed consent Adults (aged 18 years or older) Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month) Current use of a commercial hybrid closed-loop system HbA1c≤12% (measured within the past 3 months) Willing to use the SNAQ app on a daily basis for over 3 weeks The participant is willing to follow study specific instructions and share their treatment data with the study team Exclusion Criteria: Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results Previous use of SNAQ app for more than 5 days within the past 3 months Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding Severe visual impairment Severe hearing impairment Lack of reliable telephone facility for contact Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results Participant not proficient in German
Sites / Locations
- Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention
Control
The intervention group will use SNAQ app for the first 3 weeks (baseline to V1) of the study.
The control group will continue estimating the carbohydrate count using their traditional methods for the first three weeks of the study (baseline to V1).